Drug intelligence / Profile preview

Tanchuan Dropping Pills

Development stage: Preclinical
Lead developer: Hainan Haochuang Pharmaceutical
Administration: Oral

Overview

**Tanchuan Dropping Pills** are an oral Chinese herbal medicine product developed for chronic bronchitis, with traditional therapeutic positioning as an antitussive, expectorant, and anti-asthmatic treatment. In the registered bioequivalence study, exposure to the *Sophora flavescens* alkaloids matrine and oxymatrine was assessed after administration of the dropping-pill formulation versus Tanchuan Tablets; both study arms also received Phellodendron fruit oil soft capsules as a separate coadministered product. The precise molecular pharmacology of the proprietary dropping-pill product has not been established in public sources. ([synapse.patsnap.com](https://synapse.patsnap.com/drug/5fee74b8df3547d68876895b718a8ffe))

Other names: Tan Chuan Dripping Pills痰喘滴丸

Beyond the preview

Go deeper on Tanchuan Dropping Pills.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tanchuan Dropping Pills.

Explore the full profile